Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.97 +0.02 (+2.53%)
As of: Sep 30, 2026 · 10:25 AM EDT

Lineage Cell Therapeutics (LCTX) Short term Debt (2014 - 2021)

Updated

Lineage Cell Therapeutics (LCTX) posted Short term Debt of $523,000 for Q1 2021, unchanged from the prior quarter.

Analysis

Lineage Cell Therapeutics (LCTX) Short term Debt (2014 - 2021) Analysis & Trends

Since Q2 2014, Lineage Cell Therapeutics has reported Short term Debt for 10 quarters.

  • Annual Short term Debt shows a five-year compound annual growth rate of 82.3% (FY2015 to FY2020).
  • According to Business Quant data, Short term Debt for the three prior quarters was $523,000 (Q4 2020), $523,000 (Q3 2020) and $523,000 (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lineage Cell Therapeutics 245.32 Mn 43.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 523,000.00
Dec 31, 2020 523,000.00
Sep 30, 2020 523,000.00
Jun 30, 2020 523,000.00
Dec 31, 2015 26,000.00
Jun 30, 2015 3,000.00
Mar 31, 2015 17,307.00
Dec 31, 2014 31,000.00
Sep 30, 2014 44,963.00
Jun 30, 2014 57,500.00
API Access

Lineage Cell Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=LCTX&period=max&api_key=YOUR_API_KEY